Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE).
Journal for immunotherapy of cancer（2023）
摘要
NCT02636036.
更多查看译文
关键词
clinical trials as topic,immunotherapy,oncolytic viruses,therapies, investigational
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要